REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S (Colombia)

Main Activities: Diagnostic Imaging Centers
Full name: Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S Profile Updated: March 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S is based in Colombia, with the head office in Valledupar. The company operates in the Diagnostic Imaging Centers industry. Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S was incorporated on August 27, 2014. Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S currently employs 5 (2017) people. The latest financial highlights indicate a net sales revenue increase of 85.01% in 2023. Its’ total assets recorded a growth of 127.1%. The net profit margin of Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S increased by 7.73% in 2023.

Headquarters
Cl 14 14 51
Valledupar; Cesar;

Contact Details: Purchase the Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S report to view the information.
Outstanding Shares:
Purchase the Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S report to view the information.
Incorporation Date:
August 27, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Clinico Microbiologico Yexenia Ovalle Arredondo Ips-S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
85.01%
Total operating revenue
85.01%
Operating profit (EBIT)
269.68%
EBITDA
416.45%
Net Profit (Loss) for the Period
295.77%
Total assets
127.1%
Total equity
73.06%
Operating Profit Margin (ROS)
7.87%
Net Profit Margin
7.73%
Return on Equity (ROE)
14.2%
Quick Ratio
-20.26%
Cash Ratio
-2.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?